<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">03582</article-id><article-id pub-id-type="doi">10.7554/eLife.03582</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>A genetically attenuated malaria vaccine candidate based on <italic>P. falciparum b9/slarp</italic> gene-deficient sporozoites</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-15894"><name><surname>van Schaijk</surname><given-names>Ben C L</given-names></name><aff><addr-line><named-content content-type="department">Department of Medical Microbiology</named-content></addr-line>, <institution>Radboud University Nijmegen Medical Center</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15895"><name><surname>Ploemen</surname><given-names>Ivo H J</given-names></name><aff><institution>Institute for Translational Vaccinology</institution>, <addr-line><named-content content-type="city">Bilthoven</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15896"><name><surname>Annoura</surname><given-names>Takeshi</given-names></name><aff><addr-line><named-content content-type="department">Department of Tropical Medicine</named-content></addr-line>, <institution>Jikei University School of Medicine</institution>, <addr-line><named-content content-type="city">Tokyo</named-content></addr-line>, <country>Japan</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15897"><name><surname>Vos</surname><given-names>Martijn W</given-names></name><aff><addr-line><named-content content-type="department">Department of Medical Microbiology</named-content></addr-line>, <institution>Radboud University Nijmegen Medical Center</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15898"><name><surname>Lander</surname><given-names>Foquet</given-names></name><aff><addr-line><named-content content-type="department">Center for Vaccinology</named-content></addr-line>, <institution>Ghent University and University Hospital</institution>, <addr-line><named-content content-type="city">Ghent</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15899"><name><surname>van Gemert</surname><given-names>Geert-Jan</given-names></name><aff><addr-line><named-content content-type="department">Department of Medical Microbiology</named-content></addr-line>, <institution>Radboud University Nijmegen Medical Center</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15900"><name><surname>Chevalley-Maurel</surname><given-names>Severine</given-names></name><aff><addr-line><named-content content-type="department">Leiden Malaria Research Group, Parasitology</named-content></addr-line>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15901"><name><surname>van de Vegte-Bolmer</surname><given-names>Marga</given-names></name><aff><addr-line><named-content content-type="department">Department of Medical Microbiology</named-content></addr-line>, <institution>Radboud University Nijmegen Medical Center</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15902"><name><surname>Sajid</surname><given-names>Mohammed</given-names></name><aff><addr-line><named-content content-type="department">Leiden Malaria Research Group, Parasitology</named-content></addr-line>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15903"><name><surname>Franetich</surname><given-names>Jean-Francois</given-names></name><aff><addr-line><named-content content-type="department">Centre d'Immunologie et des Maladies Infectieuses</named-content></addr-line>, <institution>Université Pierre et Marie Curie-Paris 6</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15904"><name><surname>Lorthiois</surname><given-names>Audrey</given-names></name><aff><addr-line><named-content content-type="department">Centre d'Immunologie et des Maladies Infectieuses</named-content></addr-line>, <institution>Université Pierre et Marie Curie-Paris 6</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15905"><name><surname>Leroux-Roels</surname><given-names>Geert</given-names></name><aff><addr-line><named-content content-type="department">Center for Vaccinology</named-content></addr-line>, <institution>Ghent University and University Hospital</institution>, <addr-line><named-content content-type="city">Ghent</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15906"><name><surname>Meuleman</surname><given-names>Philip</given-names></name><aff><addr-line><named-content content-type="department">Center for Vaccinology</named-content></addr-line>, <institution>Ghent University and University Hospital</institution>, <addr-line><named-content content-type="city">Ghent</named-content></addr-line>, <country>Belgium</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15907"><name><surname>Hermsen</surname><given-names>Cornelius C</given-names></name><aff><addr-line><named-content content-type="department">Department of Medical Microbiology</named-content></addr-line>, <institution>Radboud University Nijmegen Medical Center</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15908"><name><surname>Mazier</surname><given-names>Dominique</given-names></name><aff><addr-line><named-content content-type="department">Centre d'Immunologie et des Maladies Infectieuses</named-content></addr-line>, <institution>Université Pierre et Marie Curie-Paris 6</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15909"><name><surname>Hoffman</surname><given-names>Stephen L</given-names></name><aff><institution>Sanaria Inc.</institution>, <addr-line><named-content content-type="city">Rockville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-15910"><name><surname>Janse</surname><given-names>Chris J</given-names></name><aff><addr-line><named-content content-type="department">Leiden Malaria Research Group, Parasitology</named-content></addr-line>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-15911"><name><surname>Khan</surname><given-names>Shahid M</given-names></name><aff><addr-line><named-content content-type="department">Leiden Malaria Research Group, Parasitology</named-content></addr-line>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-15912"><name><surname>Sauerwein</surname><given-names>Robert W</given-names></name><aff><addr-line><named-content content-type="department">Department of Medical Microbiology</named-content></addr-line>, <institution>Radboud University Nijmegen Medical Center</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country><email>Robert.Sauerwein@radboudumc.nl</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1538"><name><surname>White</surname><given-names>Nicholas J</given-names></name><role>Reviewing editor</role><aff><institution>Mahidol University</institution>, <country>Thailand</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>11</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e03582</elocation-id><supplementary-material><ext-link xlink:href="elife-03582-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>04</day><month>06</month><year>2014</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2014, van Schaijk et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>van Schaijk et al</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>A highly efficacious pre-erythrocytic stage vaccine would be an important tool for the control and elimination of malaria but is currently unavailable. High-level protection in humans can be achieved by experimental immunization with <italic>Plasmodium falciparum</italic> sporozoites attenuated by radiation or under anti-malarial drug coverage. Immunization with genetically attenuated parasites (GAP) would be an attractive alternative approach. Here we present data on safety and protective efficacy using sporozoites with deletions of two genes i.e. the newly identified <italic>b9</italic> and <italic>slarp</italic>, which govern independent and critical processes for successful liver-stage development. In the rodent malaria model, PbΔ<italic>b9</italic>Δ<italic>slarp</italic>GAP was completely attenuated showing no breakthrough infections while efficiently inducing high level protection. The human PfΔ<italic>b9</italic>Δ<italic>slarp</italic>GAP generated without drug-resistance markers were infective to human hepatocytes in vitro and to humanized mice engrafted with human hepatocytes in vivo but completely aborted development after infection. These findings support the clinical development of a PfΔ<italic>b9</italic>Δ<italic>slarp</italic>SPZ vaccine.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Stephen L Hoffman, CEO of Sanaria Inc, biotechnology company focused on whole sporozoite malaria vaccines.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments with rodent parasites performed at the LUMC (Netherlands) were approved by the Animal Experiments Committee of the Leiden University Medical Center (DEC 07171; DEC 10099) and at the RUNMC (Netherlands) by the Radboud University Experimental Animal Ethical Committee (RUDEC 2008-123, RUDEC 2008-148, RUDEC 2010-250, RUDEC 2011-022, RUDEC 2011-208). The Dutch Experiments on Animal Act is established under European guidelines (EU directive 86/609/CEE) regarding the Protection of Animals used for Experimental and Other Scientific Purposes.Human liver-uPA-SCID mice (chimeric mice) were produced as described before. The study protocol for infecting these mice with P. falciparum sporozoites was approved by the animal ethics committee of the Faculty of Medicine and Health Sciences of the Ghent University.The study protocol was approved by the animal ethics committee of the Faculty of Medicine and Health Sciences of the Ghent University.</p></fn><fn fn-type="other"><p>Human subjects: Primary human hepatocytes were isolated from healthy parts of human liver fragments which were collected during unrelated surgery in agreement with French national ethical regulations and after oral informed consent from adult patients undergoing partial hepatectomy as part of their medical treatment (Service de Chirurgie Digestive, H�pato-Bilio-Pancr�atique et Transplantation H�patique, H�pital Piti�-Salp�tri�re, Paris, France). The collection and use of this material for the purposes of the study presented here were undertaken in accordance with French national ethical guidelines under Article L. 1121-1 and article L. 1211-2</p></fn></fn-group></back></article>